Skip to main content
Y.S.H. logo

Y.S.H. — Investor Relations & Filings

Ticker · 3705 ISIN · TW0003705000 TW Financial and insurance activities
Open in API
Filings indexed 2,128 across all filing types
Latest filing 2024-08-13 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 3705

About Y.S.H.

www.yungshingroup.com

YungShin Global Holding Corporation is an investment holding company focused on the pharmaceutical and comprehensive healthcare sectors. Through its subsidiaries, the group manages an integrated value chain that spans research and development, manufacturing, and global distribution. Its diverse product portfolio includes human prescription and over-the-counter generic medicines, active pharmaceutical ingredients (APIs), animal health products, and health supplements. The company also provides cosmetics and specialty chemicals. Leveraging advanced enterprise resource planning systems to ensure operational transparency and quality control, the group serves a broad international market. Its core mission centers on delivering holistic health solutions and maintaining a robust presence across the healthcare supply chain, supported by a long-standing commitment to social welfare and community health initiatives.

Recent filings

Filing Released Lang Actions
113年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the second quarter of the fiscal year 2024 (民國113年第2季), with detailed financial data including cash flows from operating, investing, and financing activities. The presence of actual financial figures and the coverage of a period shorter than a full fiscal year indicate this is a quarterly or interim financial report. The document length is 2756 characters, which is sufficient to contain substantive financial data, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-13 Chinese
113年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed tables of consolidated equity changes for the first half of the year 2024 (民國113年上半年度) and the same period in the previous year. It includes financial data such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, unrealized gains/losses on financial assets, treasury stock, and total equity attributable to the parent company and non-controlling interests. The presence of detailed financial data for a half-year period indicates this is a comprehensive interim financial report rather than a brief announcement or a certification. The document length is 4588 characters, which is sufficient to contain substantive financial data. Therefore, this document is best classified as an Interim / Quarterly Report (IR). H1 2024
2024-08-13 Chinese
113年第2季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items. It includes actual financial figures for the second quarter of the fiscal year 113 (which corresponds to 2024) and comparative periods. The presence of comprehensive financial statements with substantive data indicates this is a financial report rather than a brief announcement or certification. The document length is 4758 characters, which is sufficient to contain detailed financial data. The content matches the characteristics of an Interim / Quarterly Report (IR), as it covers a period shorter than a full fiscal year and provides detailed financial statements. There is no indication that this is an Annual Report (10-K) or a simple announcement. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q2 2024
2024-08-13 Chinese
113年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 永信, providing information on fund loans and endorsement guarantees for the current and previous month, including cumulative balances and limits. It contains no detailed financial statements or analysis, nor does it mention any report publication or meeting. The content is regulatory in nature, reporting specific financial data related to guarantees and loans, but it is not a full financial report or announcement of a report. Given the short length (622 characters) and the nature of the data, this fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance disclosures that do not fit other categories.
2024-08-08 Chinese
113年7月營業收入
Regulatory Filings Classification · 95% confidence The document is very short (415 characters) and consists mainly of a summary table listing company codes and names, with a note about monthly revenue reporting by subsidiaries under ROC or IFRS standards. There is no detailed financial data, no report content, no management discussion, no voting results, no legal or regulatory announcements, and no indication of a specific report being attached or published. The content resembles a general regulatory or informational filing without substantive financial or corporate event details. Given the lack of specific report content and the nature of the information, the best fit is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous filings that do not fit other categories.
2024-08-08 Chinese
公告本公司解除總經理競業禁止之限制
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the lifting of a non-compete restriction on the general manager. It details the board resolution date, the manager's name and title, the permitted competitive activities, and related information about the manager's involvement in a related company. There is no financial data, no report or presentation, no voting results, no legal proceedings, no share transactions, and no mention of any report publication. The content is about management permissions and board decisions related to competitive activities, which fits best under Regulatory Filings (RNS) as it is a regulatory announcement that does not fit other specific categories.
2024-08-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.